Evidence map›Paper›PMID 39039155›Full record

ArticleMolecular psychiatry2025

Evidence for thyroid hormone regulation of amygdala-dependent fear-relevant memory and plasticity.

Stephanie A Maddox, Olga Y Ponomareva, Cole E Zaleski, Michelle X Chen, Kristen R Vella, Anthony N Hollenberg, Claudia Klengel, Kerry J Ressler

Abstract read
In one paragraph

Article in Molecular psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Stephanie A Maddox *Neurobiology of Fear Laboratory, Basic Neuroscience Division, McLean Hospital, Belmont, MA, USA.ORCID 0000-0001-7622-4535
Olga Y Ponomareva *Neurobiology of Fear Laboratory, Basic Neuroscience Division, McLean Hospital, Belmont, MA, USA.
Cole E ZaleskiNeurobiology of Fear Laboratory, Basic Neuroscience Division, McLean Hospital, Belmont, MA, USA.
Michelle X ChenNeurobiology of Fear Laboratory, Basic Neuroscience Division, McLean Hospital, Belmont, MA, USA.
Kristen R VellaJoan and Sanford I. Weill Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, Weill Cornell Medicine, New York, NY, USA.
Anthony N HollenbergJoan and Sanford I. Weill Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, Weill Cornell Medicine, New York, NY, USA.
Claudia KlengelNeurobiology of Fear Laboratory, Basic Neuroscience Division, McLean Hospital, Belmont, MA, USA.
Kerry J ResslerNeurobiology of Fear Laboratory, Basic Neuroscience Division, McLean Hospital, Belmont, MA, USA. kressler@mclean.harvard.edu.ORCID 0000-0002-5158-1103

Funding

SPARED CenterP50MH115874 · NIMH · MCLEAN HOSPITAL · PI CARLEZON, WILLIAM A. · 2019 to 2023
$13.7M
Cell Type Specific Genomic and Functional Dissection of Fear-Off Amygdala PathwaysR01MH108665 · NIMH · MCLEAN HOSPITAL · PI BOLSHAKOV, VADIM, RESSLER, KERRY J. · 2016 to 2025
$7.5M
Understanding Foxp2-Mediated Molecular Signaling in Fear LearningK08MH130802 · NIMH · MCLEAN HOSPITAL · PI Olga Y Ponomareva · 2023 to 2026
$777k
NIMH NIH HHS K08 MH130802NIMH NIH HHS P50 MH115874NIMH NIH HHS R01 MH108665U.S. Department of Health & Human Services | National Institutes of Health (NIH) MH108665
6 · The paper itself

Abstract

The amygdala is an established site for fear memory formation, and clinical studies suggest involvement of hormone signaling cascades in development of trauma-related disorders. While an association of thyroid hormone (TH) status and mood disorders is established, the related brain-based mechanisms and the role of TH in anxiety disorders are unknown. Here we examine the role that TH receptor (TR, a nuclear transcriptional repressor when unbound and a transcriptional activator when bound to TH) may have in mediating the initial formation of fear memories in the amygdala. We identified mRNA levels of TR and other TH pathway regulatory genes, including thyrotropin-releasing hormone (Trh), transthyretin (Ttr), thyrotropin-releasing hormone receptor (Trhr), type 2 iodothyronine deiodinase (Dio2), mediator complex subunit 12 (Med12/Trap230) and retinoid X receptor gamma (Rxrg) to be altered in the amygdala following Pavlovian fear conditioning. Using TH agonist and antagonist infusion into the amygdala, we demonstrated that this pathway is both necessary and sufficient for fear memory consolidation. Inhibition of TH signaling with the TR antagonist 1-850 decreased fear memory consolidation; while activation of TR with T3 (triiodothyronine) resulted in increased memory formation. Using a systemic hypothyroid mouse model, we found that intra-amygdala infusions of T3 were sufficient to rescue deficits in fear memory. Finally, we demonstrated that T3 was sufficient to activate TR-specific gene pathways in the amygdala. These findings on the role of activity-dependent TR modulation support a model in which local TH is a critical regulator of fear memory-related plasticity in the amygdala.

Indexed as

AmygdalaFearMemoryNeuronal PlasticityThyroid HormonesAnimalsConditioning, ClassicalMaleMiceMice, Inbred C57BLReceptors, Thyroid HormoneSignal TransductionReceptors, Thyroid HormoneThyroid Hormones

Identifiers

PMID39039155
PMCPMC11931561

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.